Announcements & Updates
US FDA FAERS and quinolones
Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised concern about their possible association with acute hepatic failure (AHF). Data from the US FDA Adverse Event Reporting System were evaluated for signals of AHF…
Read MoreAdvancing Toxicity Testing webinar
The Center for Alternatives to Animal Testing and the Animal-Free Safety Assessment recently held their annual meeting on advancing toxicity testing in the 21st century (TT21C). This informal event provided brief updates on cutting edge approaches in toxicology that have accrued since the publication of the 2007 U.S. National Research…
Read MoreUSC appoints Dr. Mattison distinguished professor
Dr. Donald Mattison, RSI’s Senior Vice-President and Chief Medical Officer, has accepted an appointment as a University of South Carolina Health Sciences Distinguished Professor in the in the Arnold School of Public Health (ASPH). The appointment noted that Dr. Mattison’s broad and deep career experience as a researcher and educator is impressive and…
Read MoreRSI receives National Defence funding
RSI is pleased to be the recipient of funding through the DND IDEaS COVID-19 Challenge. Under the supervision of Emma Hartnett, RSI will be developing a risk-based tool to support public health emergency response planning for COVID-19, and other infectious disease and mass casualty emergencies in the future. The safety…
Read MoreWillhite receives prestigious SOT award
Calvin C. Willhite, an Associate Expert with Risk Sciences International working on a range of toxicological risk issues, was just announced as the recipient of the prestigious 2021 Arnold Lehman Award presented annually by the Society of Toxicology for outstanding contributions to evidence-based toxicology to improve public health. Dr. Willhite specializes in human…
Read MoreRSI gives keynote
RSI experts Jennifer Go and Daniel Krewski, were recently invited to present a paper on maternal and child environmental heath during a global, virtual workshop originating in Foshan, Guangdong, China.
Read MoreRSI hosts Mitacs intern
Risk Sciences International will host Abdallah Alami as an intern in statistics with support from the Mitacs Accelerate program. This unique university-industry program supports interns at Canadian companies while completing graduate their training at Canadian universities. Mr. Alami will be completing his MSc in statistics at Carleton University under the supervision…
Read MoreDr. Mattison chairs NAM report
Compounded medications prepared by pharmacists or physicians have been used extensively throughout history as a mainstay of therapeutics. Over the past half-century – with the increasing focus on evidence based treatment the use of compounded medications substantially decreased. However, in some therapeutic areas, such as menopause, use of compounded medications…
Read MoreCOVID-19 timeline by RSI
As part of its new Risk & Crisis Communication Master Class & Boot Camp, and its ongoing commitment to keep its understanding of major public health issues current, RSI has produced a COVID-19 Timeline with emphasis on Canada and the United States, communication and citizen oriented milestones, and official pronouncements…
Read More